BC Extra | May 15, 2012
Company News

F-star names Haurum CEO, Dancer COO

Antibody company F-star Biotechnologische Forschungs und Entwicklungs GmbH (Vienna, Austria) hired John Haurum as CEO. Haurum is the former VP of research at ImClone Systems Inc. , which Eli Lilly and Co. (NYSE:LLY) acquired 2008. He...
BC Week In Review | May 14, 2012
Company News

F-star management update

F-star Biotechnologische Forschungs und Entwicklungs GmbH , Vienna, Austria   Business: Antibodies   Hired: Jane Dancer as COO, formerly VP of business development at Cellzome Ltd.; Sharon Grimster as VP of development, formerly a VP at...
BC Week In Review | Apr 30, 2012
Clinical News

Oforta fludarabine regulatory update

FDA Commissioner Margaret Hamburg revoked accelerated approval of Oforta fludarabine from Sanofi as a second-line therapy to treat B cell chronic lymphocytic leukemia. According to the agency, Sanofi asked FDA to withdraw approval of Oforta,...
BC Extra | Apr 26, 2012
Company News

FDA pulls Oforta approval

FDA Commissioner Margaret Hamburg revoked accelerated approval of Oforta fludarabine from Sanofi (Euronext:SAN; NYSE:SNY) as a second-line therapy to treat B cell chronic lymphocytic leukemia. According to the agency, Sanofi asked FDA to withdraw approval...
BC Week In Review | Apr 9, 2012
Company News

Summit management update

Summit Corp. plc (LSE:SUMM), Abingdon, U.K.   Business: Musculoskeletal, Endocrine/Metabolic, Infectious   Hired: Glyn Edwards as CEO and a director, formerly CEO of Antisoma plc  ...
BC Extra | Nov 24, 2011
Politics & Policy

BIA's Gaymond departing as CEO

The U.K. BioIndustry Association said CEO Nigel Gaymond left to pursue other opportunities. Glyn Edwards will become interim CEO. Edwards was CEO of cancer company Antisoma plc (LSE:ASM)....
BC Week In Review | Jul 18, 2011
Company News

Clavis management update

Clavis Pharma ASA (OSE:CLAVIS), Oslo, Norway   Business: Drug delivery, Cancer, Infectious   Hired: Nicholas Adams as CBO, formerly VP of business development at Antisoma plc ; he replaces Jan Alfheim, who is departing to...
BC Week In Review | Jun 20, 2011
Company News

e-Therapeutics management update

e-Therapeutics Ltd. (LSE:ETX), Newcastle, U.K.   Business: Infectious, Cancer   Hired: Daniel Elger as CFO and a director, formerly VP of marketing and communications at Antisoma plc   Departed: J.M. Cordiner as finance director  ...
BC Week In Review | May 30, 2011
Company News

Genkyotex management update

GenKyoTex S.A. , Geneva, Switzerland   Business: Pulmonary, Renal, Cardiovascular   Hired: Ursula Ney as CEO and executive director, formerly COO at Antisoma plc  ...
BioCentury | May 30, 2011
Finance

Europe's Iceberg 2011: Unlocking hidden value

The European biotech industry is now about a generation old - long enough for investors and managements to benefit from the experiences of several business cycles. While it is easy to complain about the flaws in...
Items per page:
1 - 10 of 372
BC Extra | May 15, 2012
Company News

F-star names Haurum CEO, Dancer COO

Antibody company F-star Biotechnologische Forschungs und Entwicklungs GmbH (Vienna, Austria) hired John Haurum as CEO. Haurum is the former VP of research at ImClone Systems Inc. , which Eli Lilly and Co. (NYSE:LLY) acquired 2008. He...
BC Week In Review | May 14, 2012
Company News

F-star management update

F-star Biotechnologische Forschungs und Entwicklungs GmbH , Vienna, Austria   Business: Antibodies   Hired: Jane Dancer as COO, formerly VP of business development at Cellzome Ltd.; Sharon Grimster as VP of development, formerly a VP at...
BC Week In Review | Apr 30, 2012
Clinical News

Oforta fludarabine regulatory update

FDA Commissioner Margaret Hamburg revoked accelerated approval of Oforta fludarabine from Sanofi as a second-line therapy to treat B cell chronic lymphocytic leukemia. According to the agency, Sanofi asked FDA to withdraw approval of Oforta,...
BC Extra | Apr 26, 2012
Company News

FDA pulls Oforta approval

FDA Commissioner Margaret Hamburg revoked accelerated approval of Oforta fludarabine from Sanofi (Euronext:SAN; NYSE:SNY) as a second-line therapy to treat B cell chronic lymphocytic leukemia. According to the agency, Sanofi asked FDA to withdraw approval...
BC Week In Review | Apr 9, 2012
Company News

Summit management update

Summit Corp. plc (LSE:SUMM), Abingdon, U.K.   Business: Musculoskeletal, Endocrine/Metabolic, Infectious   Hired: Glyn Edwards as CEO and a director, formerly CEO of Antisoma plc  ...
BC Extra | Nov 24, 2011
Politics & Policy

BIA's Gaymond departing as CEO

The U.K. BioIndustry Association said CEO Nigel Gaymond left to pursue other opportunities. Glyn Edwards will become interim CEO. Edwards was CEO of cancer company Antisoma plc (LSE:ASM)....
BC Week In Review | Jul 18, 2011
Company News

Clavis management update

Clavis Pharma ASA (OSE:CLAVIS), Oslo, Norway   Business: Drug delivery, Cancer, Infectious   Hired: Nicholas Adams as CBO, formerly VP of business development at Antisoma plc ; he replaces Jan Alfheim, who is departing to...
BC Week In Review | Jun 20, 2011
Company News

e-Therapeutics management update

e-Therapeutics Ltd. (LSE:ETX), Newcastle, U.K.   Business: Infectious, Cancer   Hired: Daniel Elger as CFO and a director, formerly VP of marketing and communications at Antisoma plc   Departed: J.M. Cordiner as finance director  ...
BC Week In Review | May 30, 2011
Company News

Genkyotex management update

GenKyoTex S.A. , Geneva, Switzerland   Business: Pulmonary, Renal, Cardiovascular   Hired: Ursula Ney as CEO and executive director, formerly COO at Antisoma plc  ...
BioCentury | May 30, 2011
Finance

Europe's Iceberg 2011: Unlocking hidden value

The European biotech industry is now about a generation old - long enough for investors and managements to benefit from the experiences of several business cycles. While it is easy to complain about the flaws in...
Items per page:
1 - 10 of 372